In2023,we continued to reimagine medicine to improve and extend people’s lives.Our performance shows the progress we are we are making in delivering on our purpose and creating sustainable value for society。
Broadening access to medicines
Advancing our commitment to our people,to environmental sustainability and to acting with integrity
可伸缩密封性能
Chair's letter
The shift from taking a broad market approach to going deep into select medical areas to achieve category leadership is set to guide our strategy in future。
Joerg Reinhardt 单击功能区上, 方向,方向
CEO’s letter
Our very strong financial and R&D performance underscores the benefits of our focused strategy and the progress we are making in creating value for shareholders and society。
Vas Narasimhan 单击功能区上, Chief Executive Officer